188 related articles for article (PubMed ID: 16685160)
21. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
[TBL] [Abstract][Full Text] [Related]
22. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N
Gan To Kagaku Ryoho; 2004 May; 31(5):759-61. PubMed ID: 15170988
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer.
Nagata N; Kimura M; Hirabayashi N; Tuburaya A; Murata T; Kondo K; Fukuda Y; Kobayashi M; Miyashita Y; Nakao A; Sakamoto J
Hepatogastroenterology; 2008; 55(86-87):1846-50. PubMed ID: 19102406
[TBL] [Abstract][Full Text] [Related]
26. [A phase I study of intraperitoneal plus intravenous paclitaxel against gastric cancer with peritoneal dissemination (HGCG 0301)].
Shinohara H; Okamoto S; Nishitai R; Shirakata Y; Itoi K; Yamagami K; Taki Y; Yamamoto M; Mizuno Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2027-31. PubMed ID: 17197747
[TBL] [Abstract][Full Text] [Related]
27. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
29. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
[TBL] [Abstract][Full Text] [Related]
30. [Weekly paclitaxel therapy for metastatic breast cancer].
Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
32. [A case of advanced gastric cancer treated with weekly paclitaxel with measurement of paclitaxel concentrations in blood and ascites].
Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kato J; Kojima H
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1529-31. PubMed ID: 14584291
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
[TBL] [Abstract][Full Text] [Related]
34. Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
Stathopoulos GP; Malamos NA; Aravantinos G; Rigatos S; Christodoulou Ch; Stathopoulos J; Skarlos D
Cancer Chemother Pharmacol; 2007 Jun; 60(1):123-8. PubMed ID: 17111119
[TBL] [Abstract][Full Text] [Related]
35. [A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy].
Cho H; Kanari M; Sano H; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Imada T
Gan To Kagaku Ryoho; 2003 Jan; 30(1):129-32. PubMed ID: 12557718
[TBL] [Abstract][Full Text] [Related]
36. Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.
Kim JG; Sohn SK; Song HS; Kwon KY; Do YR; Lee KH; Hyun MS; Ryoo HM; Bae SH; Park KU; Baek JH; Lee WS; Chung JS; Cho GJ; Sohn CH; Jang JS; Chung HY; Yu W
Cancer Chemother Pharmacol; 2007 Nov; 60(6):863-9. PubMed ID: 17333192
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
Charoentum C; Thongprasert S; Chewasakulyong B
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
39. [Weekly paclitaxel infusion in patients with recurrent ovarian cancer--a pilot study].
Kawagoe H; Kawata T; Nishio S; Shimomura T; Fujiyoshi K; Ishimatsu J; Tsunawaki A
Gan To Kagaku Ryoho; 2003 Jan; 30(1):151-4. PubMed ID: 12557722
[TBL] [Abstract][Full Text] [Related]
40. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
Kimura M; Koida T; Yanagita Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]